Autopsy report · NCT04552262

Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

Cause of deathNo reason given Automatic label, confidence 0.9, unverified. How labels are made.

“Terminated”

The sponsor’s own words in the registry.

Life of this trial

Ran for about 7 months before it stopped.
7 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Bayer
Sponsor type: Industry
Conditions: Moderate Chronic Kidney Disease
Interventions: BAY2327949; Placebo
Participants: 7
Sites: 1
Countries: Denmark

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.